Skip to main content

Advertisement

SpringerLink
Log in

Anti-MDA5 antibody-positive bullous dermatomyositis with thyroid carcinoma

  • Correspondence
  • Published:
European Journal of Dermatology

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Fujimoto N, Honda S, Wakabayashi M, Hamaguchi Y, Fujimoto M, Tanaka T. Anti–MDA–5 antibody–positive bullous dermatomyositis with palmar papules complicating rapidly progressive interstitial lung disease. Mod Rheumatol 2016; 26: 614–6.

    PubMed  CAS  Google Scholar 

  2. Chaisson NF, Paik J, Orbai AM, et al. A novel dermatopulmonary syndrome associated with MDA–5 antibodies:report of 2 cases and review of the literature. Medicine (Baltimore) 2012; 91: 220–8.

    Article  Google Scholar 

  3. Sato S, Hoshino K, Satoh T, et al. RNA helicase encoded by melanoma differentiation–associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis:association with rapidly progressive interstitial lung disease. Arthritis Rheum 2009; 60: 2193–200.

    Article  PubMed  CAS  Google Scholar 

  4. Sato S, Hirakata M, Kuwana M, et al. Autoantibodies to a 140–kd polypeptide, CADM–140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum 2005; 52: 1571–6.

    Article  PubMed  CAS  Google Scholar 

  5. Mitsuya J, Hara H, Hattori A, Matsunaga A, Terui T. Vesicle formation in dermatomyositis associated with colon carcinoma. Clin Exp Dermatol 2009; 34:e221–2.

    Article  Google Scholar 

  6. Fujimoto M, Hamaguchi Y, Kaji K, et al. Myositis–specific anti–155/140 autoantibodies target transcription intermediary factor 1 family proteins. Arthritis Rheum 2012; 64: 513–22.

    Article  PubMed  CAS  Google Scholar 

  7. Hamaguchi Y, Kuwana M, Hoshino K, et al. Clinical correlations with dermatomyositis–specific autoantibodies in adult Japanese patients with dermatomyositis:a multicenter cross–sectional study. Arch Dermatol 2011; 147: 391–8.

    Article  PubMed  CAS  Google Scholar 

  8. Kubo M, Sato S, Kitahara H, Tsuchida T, Tamaki K. Vesicle formation in dermatomyositis associated with gynecologic malignancies. J Am Acad Dermatol 1996; 34: 391–4.

    Article  PubMed  CAS  Google Scholar 

  9. Nishigori K, Yamamoto T, Yokozeki H. Vesiculo–bullous dermatomyositis:report of three cases. Dermatol Online J 2009; 15: 6.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Shiga University of Medical Science, Setatsukinowa, Otsu, Shiga, 520-2192, Japan

    Takuma Hayami, Kazuya Teramura, Toshihiro Tanaka & Noriki Fujimoto

Authors
  1. Takuma Hayami
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kazuya Teramura
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Toshihiro Tanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Noriki Fujimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Noriki Fujimoto.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hayami, T., Teramura, K., Tanaka, T. et al. Anti-MDA5 antibody-positive bullous dermatomyositis with thyroid carcinoma. Eur J Dermatol 28, 418–419 (2018). https://doi.org/10.1684/ejd.2018.3287

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ejd.2018.3287

Search

Navigation